5-(2-methylphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 5g

3-hydroxy-4-[2-(pyridin-2-yl)hydrazin-1-ylidene]cyclohexa-2,5-dien-1-one, 98%, 1g

DL-Ornithine hydrochloride, 95.0%, 500g

3-(2-Methoxy-ethoxy)propyne, 95%, 250mg

Carbonato de manganeso (II), mínimo 44% Mn, pa, 500 g, envase de plástico.

4-Cyanobenzenesulfonamide, 97.0%, 1g

Sodium methanesulfonothioate, 97.0%, 1g

2-(pyridin-4-yl)-1H-1,3-benzodiazole-4-carboxylic acid, 96%, 100mg

Methyl 2-formylthiazole-4-carboxylate, 95.0%, 100mg

1,2-Dibromo-3-(trifluoromethyl)benzene, 95.0%, 10g

1-Methylcyclopentanol, 95.0%, 25g

6-Chloro-5-nitropyridin-2(1H)-one, 95.0%, 250mg

3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride, 98%, 250mg